[HTML][HTML] Emerging role of tumor cell plasticity in modifying therapeutic response
Resistance to cancer therapy is a major barrier to cancer management. Conventional views
have proposed that acquisition of resistance may result from genetic mutations. However …
have proposed that acquisition of resistance may result from genetic mutations. However …
Cell spheroids: the new frontiers in in vitro models for cancer drug validation
M Chatzinikolaidou - Drug discovery today, 2016 - Elsevier
Highlights•Characteristics of the tumor microenvironment that have to be considered for the
development of 3D cell spheroid model systems for translational cancer research.•Methods …
development of 3D cell spheroid model systems for translational cancer research.•Methods …
[HTML][HTML] Therapeutic approaches targeting cancer stem cells
Y Pan, S Ma, K Cao, S Zhou, A Zhao, M Li… - Journal of cancer …, 2018 - journals.lww.com
Increasing studies have demonstrated that most tumors consisted a subpopulation of cells
with stem cell properties, known as cancer stem cells (CSCs). Accumulating evidence …
with stem cell properties, known as cancer stem cells (CSCs). Accumulating evidence …
Medulloblastoma: Molecular understanding, treatment evolution, and new developments
X Liu, C Ding, W Tan, A Zhang - Pharmacology & therapeutics, 2020 - Elsevier
Medulloblastoma (MB) is the most common childhood malignant brain tumor, accounting for
approximately 20% of all pediatric central nervous system tumors. Current standard …
approximately 20% of all pediatric central nervous system tumors. Current standard …
[HTML][HTML] Dual or multiple drug loaded nanoparticles to target breast cancer stem cells
Breast cancer stem (-like) cells (BCSCs) have been found to be responsible for therapeutic
resistance and disease relapse. BCSCs are difficult to eradicate due to their high resistance …
resistance and disease relapse. BCSCs are difficult to eradicate due to their high resistance …
Chemical, computational and functional insights into the chemical stability of the Hedgehog pathway inhibitor GANT61
This work aims at elucidating the mechanism and kinetics of hydrolysis of GANT61, the first
and most-widely used inhibitor of the Hedgehog (Hh) signalling pathway that targets Glioma …
and most-widely used inhibitor of the Hedgehog (Hh) signalling pathway that targets Glioma …
[HTML][HTML] Potential of steroidal alkaloids in cancer: perspective insight into structure–activity relationships
Y Huang, G Li, C Hong, X Zheng, H Yu… - Frontiers in …, 2021 - frontiersin.org
Steroidal alkaloids contain both steroidal and alkaloid properties in terms of chemical
properties and pharmacological activities. Due to outstanding biological activities such as …
properties and pharmacological activities. Due to outstanding biological activities such as …
[HTML][HTML] Identification of a novel chalcone derivative that inhibits Notch signaling in T-cell acute lymphoblastic leukemia
Notch signaling is considered a rational target in the therapy of several cancers, particularly
those harbouring Notch gain of function mutations, including T-cell acute lymphoblastic …
those harbouring Notch gain of function mutations, including T-cell acute lymphoblastic …
Synergistic inhibition of the Hedgehog pathway by newly designed Smo and Gli antagonists bearing the isoflavone scaffold
S Berardozzi, F Bernardi, P Infante, C Ingallina… - European Journal of …, 2018 - Elsevier
Aberrant activation of the Hedgehog (Hh) pathway is responsible for the onset and
progression of several malignancies. Small molecules able to block the pathway at the …
progression of several malignancies. Small molecules able to block the pathway at the …
Current trends in Hedgehog signaling pathway inhibition by small molecules
Abstract The Hedgehog (Hh) signaling pathway is a widely appreciated target for anticancer
therapy. However, drug resistance at the Smoothened receptor (SMO) and Hh activation …
therapy. However, drug resistance at the Smoothened receptor (SMO) and Hh activation …